Document Detail


Endothelin receptor subtype A blockade does not affect the haemodynamic recovery from haemorrhage during xenon/remifentanil or isoflurane/remifentanil anaesthesia in dogs.
MedLine Citation:
PMID:  20230551     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To test the compensatory role of endothelin-1 when acute blood loss is superimposed on anaesthesia, by characterizing the effect of systemic endothelin receptor subtype A (ET(A)) blockade on the haemodynamic and hormonal responses to haemorrhage in dogs anaesthetized with xenon/remifentanil (X/R) or isoflurane/remifentanil (I/R).
STUDY DESIGN: Prospective experimental randomized controlled study.
ANIMALS: Six female Beagle dogs, 13.4 +/- 1.3 kg.
METHODS: Animals were anaesthetized with remifentanil 0.5 microg kg(-1) minute(-1) plus either 0.8% isoflurane (I/R) or 63% xenon (X/R), with and without (Control) the systemic intravenous endothelin receptor subtype A antagonist atrasentan (four groups, n = 6 each). After 60 minutes of baseline anaesthesia, the dogs were bled (20 mL kg(-1)) over 5 minutes and hypovolemia was maintained for 1 hour. Continuous haemodynamic monitoring was performed via femoral and pulmonary artery catheters; vasoactive hormones were measured before and after haemorrhage.
RESULTS: In Controls, systemic vascular resistance (SVR), vasopressin and catecholamine plasma concentrations were higher with X/R than with I/R anaesthesia at pre-haemorrhage baseline. The peak increase after haemorrhage was higher during X/R than during I/R anaesthesia (SVR 7420 +/- 867 versus 5423 +/- 547 dyne seconds cm(-5); vasopressin 104 +/- 23 versus 44 +/- 6 pg mL(-1); epinephrine 2956 +/- 310 versus 177 +/- 99 pg mL(-1); norepinephrine 862 +/- 117 versus 195 +/- 33 pg mL(-1), p < 0.05). Haemorrhage reduced central venous pressure from 3 +/- 1 to 1 +/- 1 cm H(2)O (I/R, ns) and from 8 +/- 1 to 5 +/- 1 cm H(2)O (X/R, p < 0.05), but did not reduce mean arterial pressure, nor cardiac output. Atrasentan did not alter the haemodynamic and hormonal response to haemorrhage during either anaesthetic protocol.
CONCLUSIONS AND CLINICAL RELEVANCE: Selective ET(A) receptor blockade with atrasentan did not impair the haemodynamic and hormonal compensation of acute haemorrhage during X/R or I/R anaesthesia in dogs.
Authors:
Roland C E Francis; Claudia Höhne; Adrian Klein; Udo X Kaisers; Philipp A Pickerodt; Willehad Boemke
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-03-11
Journal Detail:
Title:  Veterinary anaesthesia and analgesia     Volume:  37     ISSN:  1467-2995     ISO Abbreviation:  Vet Anaesth Analg     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-05-11     Completed Date:  2011-01-21     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100956422     Medline TA:  Vet Anaesth Analg     Country:  England    
Other Details:
Languages:  eng     Pagination:  258-68     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany. roland.francis@charite.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anesthesia / methods,  veterinary*
Anesthesia, Inhalation / methods,  veterinary
Anesthesia, Intravenous / methods,  veterinary
Anesthetics, Inhalation*
Anesthetics, Intravenous*
Animals
Blood Loss, Surgical / physiopathology,  veterinary
Catecholamines / blood
Dog Diseases / physiopathology*
Dogs
Endothelin-1 / blood
Epinephrine / blood
Female
Hemodynamics / drug effects*
Hemorrhage / physiopathology,  veterinary*
Isoflurane*
Norepinephrine / blood
Piperidines*
Pyrrolidines / pharmacology*
Receptor, Endothelin A / antagonists & inhibitors*
Time Factors
Vascular Resistance / drug effects
Vasopressins / blood
Xenon*
Chemical
Reg. No./Substance:
0/Anesthetics, Inhalation; 0/Anesthetics, Intravenous; 0/Catecholamines; 0/Endothelin-1; 0/Piperidines; 0/Pyrrolidines; 0/Receptor, Endothelin A; 0/atrasentan; 11000-17-2/Vasopressins; 132875-61-7/remifentanil; 26675-46-7/Isoflurane; 51-41-2/Norepinephrine; 51-43-4/Epinephrine; 7440-63-3/Xenon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantifying Women's Stated Benefit-Risk Trade-Off Preferences for IBS Treatment Outcomes.
Next Document:  Comparison of three anaesthetic protocols in Bennett's wallabies (Macropus rufogriseus).